Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare diseases
that are characterized by widespread epidermal necrosis and sloughing of skin. They are …

Background Various systemic immunomodulating therapies have been used to treat toxic
epidermal necrolysis (TEN), but their efficacy remains unclear. Objective To perform a …

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening
mucocutaneous adverse drug reactions characterized by massive epidermal detachment …

Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a spectrum of acute,
delayed-type hypersensitivity reactions that affect the skin and the mucous membranes …

Importance Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are
severe drug reactions associated with a high rate of mortality and morbidity. There is no …

Background Co-trimoxazole, a sulfonamide antibiotic, is used to treat a variety of infections
worldwide, and it remains a common first-line medicine for prophylaxis against …

Adverse drug reactions involving the skin are commonly known as drug eruptions. Severe
drug eruption may cause severe cutaneous adverse drug reactions (SCARs), which are …

Severe cutaneous adverse reactions to medications (SCARs) are dose-dependent
manifestations of hypersensitivity phenotypes. Drug reaction with eosinophilia and systemic …

Background The SCORTEN score is a specific predictor of mortality for patients with Stevens–
Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). There is little evidence in …

Mycoplasma pneumoniae‐induced rash and mucositis is the most accurate diagnosis for
patients with blistering mucocutaneous disease provoked by an infection. Recent literature …